◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

RECURSION PHARMACEUTICALS, INC.

CIK: 1601830 SIC: 2836
$74.68M
Revenue
$-644.76M
Net Income
4.99%
Gross Margin
-867.87%
Op. Margin
$-725.42M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 14 of 15 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
+ Total Revenue $35.54M $5.17M $19.22M $14.74M $4.55M $26.08M $14.42M $13.79M $10.89M $10.53M $11.02M $12.13M $13.68M $13.16M
Revenue Growth % (YoY) 681.7% -80.2% 33.3% 6.9% -58.3% 147.6% 30.9% 13.7% -20.4% -20.0% nan% nan% nan% nan%
Cost of Revenue $14.28M $14.69M $20.16M $21.83M $12.79M $12.08M $9.20M $11.17M $9.88M $10.88M $9.38M $12.45M $10.84M $15.41M
+ Gross Profit $21.26M $-9.51M $-938.00K $-7.08M $-8.25M $14.00M $5.22M $2.63M $1.01M $-344.00K $1.64M $-314.00K $2.84M $-2.25M
Gross Margin % 59.8% -183.8% -4.9% -48.0% -181.4% 53.7% 36.2% 19.1% 9.3% -3.3% 14.8% -2.6% 20.7% -17.1%
Operating Expenses $143.87M $177.38M $195.45M $206.11M $188.31M $124.44M $114.96M $110.13M $109.82M $110.08M $92.73M $82.00M $74.66M $75.73M
Research & Development $95.94M $121.06M $128.64M $129.63M $98.33M $74.60M $73.93M $67.56M $69.48M $70.01M $55.06M $46.68M $43.98M $40.84M
+ Operating Income $-108.33M $-172.20M $-176.23M $-191.37M $-183.77M $-98.35M $-100.54M $-96.34M $-98.93M $-99.55M $-81.72M $-69.86M $-60.98M $-62.57M
Operating Margin % -304.8% -3327.6% -916.8% -1297.9% -4042.4% -377.1% -697.4% -698.4% -908.4% -945.1% -741.7% -575.8% -445.9% -475.5%
Interest Expense - - - - - - - - $60.00K $36.00K $25.00K $13.00K $13.00K $42.00K
Other Income/Expense $232.00K $9.95M $4.33M $-11.28M $4.87M $2.68M $2.48M $4.19M $1.87M $6.53M $4.99M $4.54M $3.49M $2.13M
Income Before Tax $-108.10M $-162.25M $-171.90M $-202.65M $-178.90M $-95.67M $-98.06M $-92.15M $-97.06M - - - - -
Income Tax Expense $20.00K $3.00K - $-158.00K $7.00K $167.00K $-523.00K $-779.00K $-4.06M - - - - -
+ Net Income $-108.12M $-162.25M $-171.90M $-202.49M $-178.91M $-95.84M $-97.54M $-91.37M $-93.00M $-93.02M $-76.73M $-65.33M $-57.49M $-60.45M
Net Margin % -304.2% -3135.3% -894.2% -1373.3% -3935.5% -367.5% -676.6% -662.4% -853.9% -883.1% -696.4% -538.4% -420.4% -459.3%
Basic EPS -0.17 -0.36 -0.41 -0.50 -0.57 -0.34 -0.40 -0.39 -0.42 -0.43 -0.38 -0.34 -0.30 -0.35
Diluted EPS -0.17 -0.36 -0.41 -0.50 -0.57 -0.34 -0.40 -0.39 -0.42 -0.43 -0.38 -0.34 -0.30 -0.35
Basic Shares Outstanding - 447.0M 417.4M 402.8M 20.8M 282.6M 242.2M 236.0M 4.8M 214.3M 201.4M 191.6M 3.4M 173.4M
Diluted Shares Outstanding - 447.0M 417.4M 402.8M 20.8M 282.6M 242.2M 236.0M 4.8M 214.3M 201.4M 191.6M 3.4M 173.4M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Cash & Cash Equivalents $743.29M $659.84M $525.11M $500.45M $594.35M $427.65M $474.34M $296.33M $391.56M $387.32M $405.87M $473.14M $549.91M $454.65M
Short-term Investments - - - - - - - - - - - - - -
Accounts Receivable - - - - - - - - - - - - - -
Other Current Assets $28.57M $29.22M $37.34M $32.02M $67.71M $42.72M $43.73M $41.49M $40.25M $17.78M $18.77M $15.61M $15.87M $13.25M
Total Current Assets $812.85M $714.11M $587.16M $584.14M $714.27M $474.17M $522.38M $343.62M $438.14M $410.52M $431.02M $492.12M $569.81M $481.62M
Property Plant & Equipment $103.93M $111.71M $120.04M $126.83M $141.06M $84.41M $83.63M $86.72M $86.51M $86.25M $89.77M $90.00M $88.19M $85.78M
Goodwill $162.16M $162.04M $164.27M $158.11M $148.87M $52.06M $52.06M $52.06M $52.06M $52.75M $60.52M $801.00K $801.00K $801.00K
Intangible Assets $309.90M $322.34M $341.32M $335.79M $335.86M $34.09M $38.21M $33.08M $36.44M $39.46M $42.76M $1.32M $1.31M $1.46M
Other Non-current Assets $12.75M $14.66M $9.42M $14.78M $8.82M $360.00K $308.00K $254.00K $261.00K $155.00K $110.00K $82.00K - -
Total Assets $1.47B $1.40B $1.30B $1.31B $1.45B $726.50M $775.86M $557.85M $653.70M $630.83M $666.70M $627.37M $701.29M $611.53M
Accounts Payable $18.12M $13.94M $19.31M $25.09M $21.61M $2.26M $3.76M $5.12M $3.95M $4.26M $2.09M $4.25M $4.59M $3.89M
Accrued Liabilities $70.23M $53.10M $64.28M $56.80M $81.87M $40.60M $33.40M $26.07M $46.63M $39.81M $32.87M $25.04M $32.90M $26.76M
Deferred Revenue $37.60M $47.36M $39.69M $39.65M $61.77M $49.58M $32.20M $36.62M $36.43M $44.00M $73.11M $57.76M $56.73M $46.75M
Total Current Liabilities $147.71M $155.10M $164.03M $141.98M $187.47M $108.89M $86.08M $73.92M $93.17M $94.12M $113.96M $92.15M $100.27M $83.04M
Long-term Debt $9.56M $11.90M $14.20M $16.45M $19.02M $20.51M $22.92M - $1.10M - - - - -
Deferred Tax Liabilities $23.25M $23.31M $23.78M $22.44M $16.57M $168.00K - $528.00K $1.34M $1.93M $4.34M - - -
Other Non-current Liabilities $2.08M $1.03M $1.56M $4.79M $4.73M $3.00M $3.00M - - - - - - -
Total Liabilities $343.26M $352.58M $383.21M $371.29M $413.82M $201.94M $191.41M $156.70M $190.26M $192.86M $197.74M $197.19M $215.48M $223.50M
Common Stock $5.00K $5.00K $4.00K $4.00K $4.00K $3.00K $3.00K $2.00K $2.00K $2.00K $2.00K $2.00K $2.00K $2.00K
Retained Earnings $-2.08B $-1.97B $-1.81B $-1.63B $-1.43B $-1.25B $-1.16B $-1.06B $-967.62M $-874.63M $-781.61M $-704.88M $-639.56M $-582.06M
Total Stockholders Equity $1.13B $1.05B $919.15M $933.95M $1.03B $524.56M $584.45M $401.15M $463.44M $437.97M $468.96M $430.18M $485.81M $388.03M
Total Liabilities & Equity $1.47B $1.40B $1.30B $1.31B $1.45B $726.50M $775.86M $557.85M $653.70M $630.83M $666.70M $627.37M $701.29M $611.53M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Net Income $-108.12M $-162.25M $-374.38M $-202.49M $-178.91M $-284.75M $-97.54M $-91.37M $-93.00M $-93.02M $-76.73M $-65.33M $-57.49M $-181.98M
Depreciation & Amortization $19.48M $64.22M $43.18M $19.33M $12.95M $23.54M $16.34M $7.38M $7.55M $16.85M $9.27M $3.73M $3.21M $8.54M
Stock-based Compensation $23.76M $87.46M $62.22M $36.06M $30.78M $50.90M $32.65M $16.13M $16.09M $37.42M $20.62M $8.81M $7.70M $20.21M
Change in Payables $4.42M $-7.04M $-1.15M $3.69M $8.12M $-1.69M $-174.00K $1.17M $-317.00K $-670.00K $-2.86M $-339.00K $695.00K $1.07M
Operating Cash Flow $-46.07M $-325.74M $-208.38M $-131.96M $-115.43M $-243.74M $-184.52M $-102.30M $-74.08M $-213.70M $-140.78M $-73.32M $-44.75M $-38.78M
Capital Expenditure $1.24M $5.22M $4.98M $1.83M $1.30M $12.40M $7.83M $6.65M $2.07M $9.89M $9.14M $5.17M $7.98M $29.08M
Acquisitions - - - - $-277.10M - - - $71.00K $-1.92M $-1.92M - - -
Purchases of Investments - $3.81M $1.50M $1.00M - - - - - - - - - -
Investing Cash Flow $-1.24M $-15.63M $-13.08M $-7.27M $275.46M $-15.40M $-10.84M $-6.65M $-2.49M $-7.74M $-7.39M $-5.34M $-7.98M $201.23M
Debt Repayment - - - - - - $52.00K $26.00K $694.00K $72.00K $48.00K $24.00K $23.00K $67.00K
Stock Issued $133.38M $395.48M $141.02M $41.02M $11.03M $289.39M $272.42M $10.87M $78.09M - - - - -
Financing Cash Flow $132.01M $389.53M $138.19M $40.53M $10.64M $293.48M $277.02M $13.90M $80.66M $59.47M $5.71M $1.92M $147.26M $7.09M
Net Change in Cash $86.78M $64.12M $-69.18M $-93.87M $167.19M $34.41M $81.33M $-95.28M $4.22M $-161.91M $-142.29M $-76.74M $94.22M $169.54M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $5.17M $26.08M $39.14M $54.29M
Cost of Revenue $14.69M $12.08M $56.68M $32.44M
Operating Expenses $177.38M $124.44M $578.94M $349.53M
Research & Development $121.06M $74.60M $379.33M $216.09M
Operating Income $-172.20M $-98.35M $-539.80M $-295.24M
Other Income/Expense $9.95M $2.68M $3.00M $9.35M
Income Before Tax $-162.25M $-95.67M $-536.79M $-285.89M
Income Tax Expense $3.00K $167.00K $-156.00K $-1.13M
Net Income $-162.25M $-95.84M $-536.64M $-284.75M
Basic EPS -0.36 -0.34 -1.27 -1.12
Diluted EPS -0.36 -0.34 -1.27 -1.12
Basic Shares Outstanding $446.99M $282.58M $422.64M $253.45M
Diluted Shares Outstanding $446.99M $282.58M $422.64M $253.45M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $659.84M $594.35M
Other Current Assets $29.22M $38.11M
Total Current Assets $714.11M $714.27M
Property Plant & Equipment $111.71M $141.06M
Goodwill $162.04M $148.87M
Intangible Assets $322.34M $335.86M
Other Non-current Assets $14.66M $8.82M
Total Assets $1.40B $1.45B
Accounts Payable $13.94M $21.61M
Accrued Liabilities $53.10M $81.87M
Deferred Revenue $47.36M $61.77M
Total Current Liabilities $155.10M $187.47M
Long-term Debt $11.90M $19.02M
Deferred Tax Liabilities $23.31M $16.57M
Other Non-current Liabilities $1.03M $4.73M
Total Liabilities $352.58M $413.82M
Common Stock $5.00K $4.00K
Retained Earnings $-1.97B $-1.43B
Total Stockholders Equity $1.05B $1.03B
Total Liabilities & Equity $1.40B $1.45B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-162.25M $-95.84M $-536.64M $-284.75M
Depreciation & Amortization - - $64.22M $23.54M
Stock-based Compensation - - $87.46M $50.90M
Change in Payables - - $-7.04M $-1.69M
Operating Cash Flow - - $-325.74M $-243.74M
Capital Expenditure - - $5.22M $12.40M
Purchases of Investments - - $3.81M -
Investing Cash Flow - - $-15.63M $-15.40M
Stock Issued - - $395.48M $289.39M
Financing Cash Flow - - $389.53M $293.48M
Net Change in Cash - - $64.12M $34.41M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...